Skip to main content

Weight Loss Drug Ozempic Linked to Lower Depression and Anxiety Risk

Published on June 22, 2026, 1:10 p.m.
Weight Loss Drug Ozempic Linked to Lower Depression and Anxiety Risk

Topic: Health

A new study found that a weight loss drug called Ozempic is linked to fewer psychiatric hospital visits and less time off work due to mental health conditions. The research showed a strong link between the drug's use and improved mental health outcomes.

Scientists have discovered an unexpected benefit of medications used to treat type 2 diabetes and obesity. These drugs, including Ozempic, may also help reduce the risk of depression and anxiety. A large study found that people who took these medications were less likely to visit psychiatric hospitals or take time off work due to mental health issues. The study looked at data from nearly 100,000 individuals in Sweden over a 13-year period. Researchers compared times when people took the drugs with times when they didn't. They found that during periods of drug use, hospital visits and sick leave dropped by 42%. The risk of depression was 44% lower, while anxiety disorders were reduced by 38%. These findings were published in a leading psychiatry journal called The Lancet Psychiatry.

The study's authors are from the University of Eastern Finland, Karolinska Institutet in Sweden, and Griffith University in Australia. They analyzed data from Swedish national health registers to investigate this connection between weight loss drugs and mental health. The results showed that these medications may have a positive impact on mental well-being.

The researchers cannot explain exactly how the medications affect mental health, but they found a strong association between drug use and improved outcomes. It is possible that the medications help reduce alcohol consumption, improve body image, or provide relief from better glycemic control in diabetes.

Why It Matters

This study's findings could be important for Indian students who may struggle with depression and anxiety while dealing with academic pressures. Understanding how certain medications can impact mental health might lead to new approaches to managing these conditions.

Key Facts

  • The study looked at data from nearly 100,000 individuals in Sweden over a 13-year period.
  • During periods of drug use, hospital visits and sick leave dropped by 42%.
  • The risk of depression was 44% lower, while anxiety disorders were reduced by 38%
  • The medications may help reduce alcohol consumption, improve body image, or provide relief from better glycemic control in diabetes
  • The study's findings were published in The Lancet Psychiatry

Key Terms

GLP-1 receptor agonists
Medications used to treat type 2 diabetes and obesity

Implications

This study's findings could be important for Indian students who may struggle with depression and anxiety while dealing with academic pressures. Understanding how certain medications can impact mental health might lead to new approaches to managing these conditions.


Source: https://www.sciencedaily.com/releases/2026/05/260502233924.htm

Journal Reference:

  1. Heidi Taipale, Mark Taylor, Markku Lähteenvuo, Ellenor Mittendorfer-Rutz, Antti Tanskanen, Jari Tiihonen. Association between GLP-1 receptor agonist use and worsening mental illness in people with depression and anxiety in Sweden: a national cohort study. The Lancet Psychiatry, 2026; 13 (4): 327 DOI: 10.1016/S2215-0366(26)00014-3

Leave a Comment

Name
Email
Body
... ...

Get Exclusive Insights

with Every Issue

JoinShalyamNewsletter

Stay ahead in education, research, and innovation—straight to your inbox.